Eveslage M

ORCID: 0000-0002-8802-1134 · 1 paper in corpus

nonrandomized-trial 2016

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

The Lancet. Haematology ·doi:10.1016/S2352-3026(15)00251-3

BACKGROUND: Livedoid vasculopathy is a thrombotic skin disease characterised by recurrent occlusion of the cutaneous microcirculation in lower extremities, which results in skin infarctions with painful ulcerations and irreversible scar for…